Patient experience with a new teriparatide delivery device

Author： Dore Robin K.   Feldman Robert G.   Taylor Kathleen A.   See Kyoungah   Dalsky Gail P.   Warner Margaret R.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.10, 2009-10, pp. : 2413-2422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initial experience with teriparatide in the United States

By Gold Deborah T.   Pantos Barbara S.   Masica Daniel N.   Misurski Derek A.   Marcus Robert  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 703-708

Informa Healthcare

Access to resources Recommend Favorite

Principles and initial experience of a new device for dissection and hemostasis

By Gözen A. S.   Teber D.   Rassweiler J. J.  

Minimally Invasive Therapy and Allied Technologies, Vol. 16, Iss. 1, 2007-01 ,pp. : 58-65

Informa Healthcare

Access to resources Recommend Favorite

Persistence with teriparatide in patients with osteoporosis: the UK experience

By Arden N.   Earl S.   Fisher D.   Cooper C.   Carruthers S.   Goater M.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1626-1629

Springer Publishing Company

Access to resources Recommend Favorite

Effects of teriparatide retreatment in a patient with β‐thalassemia major

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2905-2910

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comments on Initial experience with teriparatide in the United States

By Harper Kristine D.   Krege John H.   Marcus Robert   Mitlak Bruce H.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1927-1927

Informa Healthcare

Access to resources Recommend Favorite